AU3582600A - Anticonvulsant derivatives useful in treating transformed migraine - Google Patents

Anticonvulsant derivatives useful in treating transformed migraine

Info

Publication number
AU3582600A
AU3582600A AU35826/00A AU3582600A AU3582600A AU 3582600 A AU3582600 A AU 3582600A AU 35826/00 A AU35826/00 A AU 35826/00A AU 3582600 A AU3582600 A AU 3582600A AU 3582600 A AU3582600 A AU 3582600A
Authority
AU
Australia
Prior art keywords
derivatives useful
anticonvulsant derivatives
transformed migraine
treating transformed
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU35826/00A
Other languages
English (en)
Inventor
Doreen L. Potter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of AU3582600A publication Critical patent/AU3582600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU35826/00A 1999-01-21 2000-01-20 Anticonvulsant derivatives useful in treating transformed migraine Abandoned AU3582600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11654499P 1999-01-21 1999-01-21
US60116544 1999-01-21
PCT/US2000/001382 WO2000042995A2 (fr) 1999-01-21 2000-01-20 Derives anticonvulsivants utiles dans le traitement de la migraine dite transformee

Publications (1)

Publication Number Publication Date
AU3582600A true AU3582600A (en) 2000-08-07

Family

ID=22367829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU35826/00A Abandoned AU3582600A (en) 1999-01-21 2000-01-20 Anticonvulsant derivatives useful in treating transformed migraine

Country Status (3)

Country Link
AR (1) AR022321A1 (fr)
AU (1) AU3582600A (fr)
WO (1) WO2000042995A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008545650A (ja) 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
EA200870556A1 (ru) 2006-05-19 2009-06-30 Янссен Фармацевтика Н.В. Комбинированная терапия в лечении эпилепсии и родственных расстройств
NZ590682A (en) 2008-06-23 2012-09-28 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN110346004B (zh) * 2019-08-16 2020-08-21 杭州山科智能科技股份有限公司 一种双声道超声时差法的流量测量数据融合方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US5998380A (en) * 1995-10-13 1999-12-07 New England Medical Center Hospitals, Inc. Treatment of migraine
EP0932400B1 (fr) * 1996-10-08 2002-10-16 Ortho-McNeil Pharmaceutical, Inc. Derives d'anticonvulsifs utiles dans le traitement de la douleur neuropathique

Also Published As

Publication number Publication date
AR022321A1 (es) 2002-09-04
WO2000042995A2 (fr) 2000-07-27
WO2000042995A3 (fr) 2000-11-30

Similar Documents

Publication Publication Date Title
GB9912411D0 (en) Compounds useful in therapy
GB9912413D0 (en) Compounds useful in therapy
AU3582600A (en) Anticonvulsant derivatives useful in treating transformed migraine
AUPP995799A0 (en) Improvements in hinges
AU1538901A (en) Polymersation process
GB9912410D0 (en) Compounds useful in therapy
CA2361584A1 (fr) Derives d'agent anti-convulsif utilises dans le traitement de l'autisme
GB9912415D0 (en) Compounds useful in therapy
GB9912416D0 (en) Compounds useful in therapy
AU6006800A (en) Treating cells
IL144943A0 (en) Anticonvulsant derivatives useful in treating essential tremor
AU7308300A (en) Agents for reducing cholesterol-uptake and liquid-uptake
MXPA01011014A (es) Derivados anticonvulsivos utiles en el tratamiento de dependencia de cocaina.
AU2113700A (en) Method for increasing the efficiency in trade
AU5795600A (en) Body repair apparatus
AU3957797A (en) Anticonvulsant derivatives useful in treating psoriasis
AU2680200A (en) Treating metal surfaces
AU1676299A (en) Improvements in flocculants
AU4157600A (en) Machine for treatment of plate-shaped objects
AU6004200A (en) Process for innocuating an element in steel
AU4971600A (en) Immunopotentiator agents
AU7394701A (en) Method and system for insuring an investment in stocks and the like
AU3808800A (en) Compounds for use in therapy
AU1342301A (en) Improvements in water generating devices
AUPQ259799A0 (en) Process and solution

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase